Biocontractsp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2005-07-12
Share capital
78,500.00 PLN
Registered address
Zambrowska 36, 61-051 Poznań, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2023 – the filing deadline has passed. 5 of 5 financial statements were filed late (the longest delay 1091 days for 2019).

  • 2023not filed
  • 202215/11/2023
  • 202115/11/2023
  • 202015/11/2023
  • 201911/10/2023
  • 201820/10/2020
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2022.

Results vs industry

Revenue
This companyUSD 2.69kMedianUSD 917.74kAverageUSD 25.73m
Net profit
This companyUSD -58.93kMedianUSD 14.44kAverageUSD 2.75m
Operating costs
This companyUSD 56.18kMedianUSD 860.03kAverageUSD 21.34m
Assets
This companyUSD 2.32mMedianUSD 883.09kAverageUSD 31.39m

Authorized Representatives

Andrzej Adam Mackiewicz – President of the Management Board
Teresa Olga Rybińska – Attorney-in-fact (sole)

Manner of representation

In the case of a one-person management board, declarations of will on behalf of the company are made by the sole member of the management board. In the case of a multi-member management board, declarations of will on behalf of the company are made by each member of the management board independently.

Ownership

OwnerSharesShare valueStake
Andrzej Adam Mackiewiczage 73
85$11,480.2854.1401%
63$8,508.9140.1274%
Others
9$1,215.565.7325%

Beneficial owners

Person

Bank accounts

Was a VAT taxpayer from 2005-07-26 to 2022-03-22.

Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

5 public aid cases recorded, with a total value of $16,275.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$242
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$258
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$3,638

European Funds

ProjectEU co-financing
Grant fp7 - 310337 - cosmophos-nano
$402.4K

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Change history

DateEvent
2017-12-13PKD change
2009-01-02Share capital increase
2009-01-02Switch to PKD 2007
2005-07-12Entered in the register

FAQ

Last updated: 2026-04-11